Search results
Results from the WOW.Com Content Network
The main goal of diabetes management is to keep blood glucose (BG) levels as normal as possible. [1] If diabetes is not well controlled, further challenges to health may occur. [1] People with diabetes can measure blood sugar by various methods, such as with a BG meter or a continuous glucose monitor, which monitors over several days. [2]
The group has developed a wide range of evidence-based guidelines to improve quality of care and collaborated with a number of other stakeholders. [2] Since its establishment it developed several evidence-based guidelines or wherever possible expert consensus to drive quality of inpatient diabetes care.
Automated insulin delivery systems are automated (or semi-automated) systems designed to assist people with insulin-requiring diabetes, by automatically adjusting insulin delivery in response to blood glucose levels. Currently available systems (as of October 2020) can only deliver (and regulate delivery of) a single hormone—insulin.
In 2020, Diabetes Severity Score (DISSCO) was developed which is a tool that might better than HbA1c identify if a person's condition is declining. [26] [160] It uses a computer algorithm to analyse data from anonymised electronic patient records and produces a score based on 34 indicators. [161] [160]
Discover the latest breaking news in the U.S. and around the world — politics, weather, entertainment, lifestyle, finance, sports and much more.
Indigo states that it is developing a CGM called a "continuous multi-metabolite monitoring system (CMM)". It is designed to provide people living with diabetes access to information on their glucose and other metabolite levels at any given time. [44] It has yet to attain regulatory approval. The company completed a clinical trial in April 2024 ...
Drugs used in diabetes treat types of diabetes mellitus by decreasing glucose levels in the blood. With the exception of insulin , most GLP-1 receptor agonists ( liraglutide , exenatide , and others), and pramlintide , all diabetes medications are administered orally and are thus called oral hypoglycemic agents or oral antihyperglycemic agents.
CIHI uses data from governments and hospitals across Canada to determine comparative statistics and costing algorithms that are available for use by healthcare ministries, hospital boards and the general public. According to former CIHI president and CEO Richard Alvarez, CIHI's scope of research and data tracking is wide-ranging and broad. [20]